Added to YB: 2026-05-26
Pitch date: 2026-03-16
PRTC [bullish]
PureTech Health plc
+14.1%
current return
Author Info
No bio for this author
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
N/A
Pitch Price
GBP 1.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-3.81
EV/Sales
N/A
Sector
Biotechnology
Category
value
PureTech Health plc - $PRTC
PRTC: Biotech holding co at $400M FD cap owns: $166M NPV (13% discount) from 2% Cobenfy royalty >$2B sales + milestones; 35.1% of Seaport ($733M post Series B, Arch/Third Rock backed) w/ SPT-300 oral allopregnanolone Ph2b MDD (March '27 readout), SPT-320 agomelatine prodrug for MDD/GAD; 100% Celea raising 1H26 for deupirfenidone Ph3 in IPF (Ph2: 81% FVC decline reduction vs pbo). Founded/sold Karuna to BMY for $14B. Cash to 2028.
Read full article (10 min)